Kyle Rhodes joined Crosstree Capital Partners as an Analyst. Prior to joining full-time, he was an intern on the investment banking team at Crosstree. He was also a Portfolio Manager for the Max Adler Student Managed Investment Fund, where he focused primarily on the biopharma industry. Kyle holds a B.S. in Biomedical Sciences with a minor in Biophysics from the University of South Florida and an M.S. in Finance from Vanderbilt University.